Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Visceral leishmaniasis unresponsive to antimonial drugs i. clinical and immunological studies
Authors: A. D.M. Bryceson
J. D. Chulay
May Ho
M. Mugambii
J. B. Were
R. Muigai
C. Chunge
G. Gachihi
J. Meme
G. Anabwani
S. Bhatt
Kenya Medical Research Institute
Army Medical Research Unit
CASE School of Medicine
University of Nairobi Medical School
Walter Reed Army Institute of Research
Mahidol University
Keywords: Immunology and Microbiology;Medicine
Issue Date: 1-Jan-1985
Citation: Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.79, No.5 (1985), 700-704
Abstract: Ten Kenyan patients with visceral leishmaniasis, unresponsive to sodium stibogluconate at a dose of 16 to 20 mg Sb/kg/day given for 30 to 98 days, have been studied clinically and immunologically and compared with 57 antimony-responsive patients. Pulmonary tuberculosis and previous treatment with antimonial drugs were the only factors which were more common in unresponsive patients. The degree of immunosuppression and rate of recovery of immunoreactivity did not differ between antimony-responsive and -unresponsive patients. Only one patient had never been treated before (primary unresponsiveness). In the other nine patients secondary unresponsiveness occurred after one or more treatment courses, suggesting that the parasite developed resistance to antimony. Antimony-unresponsiveness in visceral leishmaniasis is a serious problem numerically, clinically and economically. A plea is made that the initial treatment of visceral leishmaniasis should be adequate in dose and duration. © Oxford University Press.
ISSN: 18783503
Appears in Collections:Scopus 1969-1990

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.